Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Bench issues notice to all States also The Supreme Court on Monday expressed serious concern over clinical trial of drugs on human beings and issued notice to all States through their Chief Secretaries for their response. Hearing a petition filed by the Swasthya Adhikar Manch, highlighting the menace, a Bench …
In the past two years, clinical trials in India have come increasingly under public scrutiny. As a result, clinical research organisations (CROs), companies that conduct clinical trials for drug makers, are somewhat under pressure. However, leading CROs in the country, such as Quintiles, are riding on the hope that they …
The Supreme Court on Monday asked the Centre to provide details of clinical trials conducted throughout the country since June 2005, their side effects, and deaths, if any, as well as the quantum of compensation paid to victims. “We are concerned with the lives of human beings who become subjects …
Expressing concern over the alleged use of humans as guinea pigs by pharmaceutical companies, the Supreme Court on Monday directed the Centre to submit details of clinical trials of drugs conducted across the country as well as their side effects and deaths, if any. A bench of Justices R.M. Lodha …
GoM had proposed a new pricing mechanism, but judges had said at an earlier hearing the current formula should stay The government is likely to formally tell the Supreme Court about the need to change the existing drug pricing mechanism. At the previous hearing on the issue last Wednesday, SC …
Why don't you sell it for Rs.5? Rs.1.2 lakh per month is too high." On September 11, Supreme Court Justices Aftab Alam and Ranjana Desai posed that question to Swiss drugmaker Novartis AG, fighting to patent its expensive cancer drug Glivec. The question wasn't just judicial speculation or indeed wit. …
A Supreme Court order on drug price control on Wednesday has caused confusion with some interpreting it to mean the retention of cost-based pricing which will help patients. The apex court on Wednesday asked the government not to alter the existing drug price structure, sparking speculation about the impact of …
Wants government to firm up a date by which essential drugs will be notified The Supreme Court on Wednesday told the Union government that in the name of bringing essential drugs under pricing control it should not alter the price system. A Bench of Justices G.S. Singhvi and S.J. Mukhopadhaya …
The Supreme Court has given the government a week to frame a final pharma pricing policy, failing which the apex court may pass an interim order in public interest. A Bench, headed by Justice G S Singhvi, posted the matter for next hearing on October 9. In an observation, the …
The All-India Chemists and Distributors’ Federation has expressed displeasure at the method proposed by the Group of Ministers to fix the cost of 348 drugs that have recently been brought under the National List of Essential Medicines. AICDF president Kailash Gupta said: “The method recommended by the GOM in fixing …
Fixed drug combinations are a major marketing strategy in India but it can compromise the rational use of medicines. In this study we compared the fixed drug combinations and dosage forms in the hospital pharmacy before and after introducing the essential drug list. We also compared the Hospital Essential Drug …
The move could further delay implementation of the policy All India Drug Action Network, the non-government organisation that forced the government to regulate prices of 348 essential drugs, is set to challenge the pricing mechanism finalised by a group of ministers in the Supreme Court. The move could further delay …
The drug pricing formula recommended by a ministerial panel will erode the revenues of pharmaceutical companies by about . 1,300 crore, according to market research firm IMS Health. Among these companies, Ranbaxy, GlaxoSmithKline, Dr Reddy’s and Novartis would be affected the most, it added. The panel on Thursday decided to …
Recommends prices of 348 drugs be fixed at weighted average price of brands with more than 1% market share. The Group of Ministers (GoM) set up to determine the country’s drug pricing policy will recommend that retail prices of 348 essential drugs be fixed at the weighted average price of …
New Delhi: India will, for the first time, put a cap on the maximum price at which essential drugs can be sold in the country. These include commonly used AIDS and cancer drugs, besides a horde of painkillers, TB drugs, sedatives, lipid lowering agents and steroids. In a landmark decision, …
The Group of Ministers set up to propose a new drug-pricing policy on Thursday recommended a market-based mechanism to regulate prices of 348 essential medicines. The GoM has proposed to cap prices of these medicines at the weighted average price of drugs with a minimum of one per cent market …
Aiming to secure the safety of people involved in drug trials in the country, the Government is in the process of framing guidelines for awarding compensation in cases of death during these trials. The hallmark of the new guidelines would be the fixing of minimum mandatory compensation to be paid …
The Novartis case highlights the need for innovation in the public interest. The Supreme Court has commenced final hearings on a case brought before it by the Swiss pharmaceutical company, Novartis. The case disputes the denial of a patent on Novartis’s anti-cancer drug Glivec. Novartis’s position is that incentives to …
New Delhi The government is planning to tighten the regulatory landscape of the R4,500-crore vitamins and neutraceuticals market in the country. Different arms of government — the drug regulator, Drug Controller General of India (DCGI), and the food regulator, Food Safety and Standards Authority of India (FSSAI) — are taking …
New Delhi The International Cri-minal Police Organisation, popularly known as Interpol, wants to assist the Indian government in its effort to clamp down on the alleged ‘fake drugs’ network in the country. While the France-headquartered agency wants New Delhi and India’s generic drug companies to sign up for the Interpol …
